Breast
Progress in genetic testing, such as BRCA1 and BRCA2 mutations, has transformed preventative strategies. Targeted therapies like HER2 inhibitors and advancements in hormone therapy have significantly improved survival rates.
Innovative Medicines
Patients with a wide range of life-threatening and debilitating illnesses today live in the hope tomorrow will bring a new medicine that will improve or even save their life. America’s biopharmaceutical research companies are researching and developing new medicines to meet unmet need and continuing research and development even after U.S. Food and Drug Administration (FDA) approval, all with the goal of improving patients’ health, quality of life, and saving lives.
AI maps molecular interaction that could improve cancer research
A new study from Oregon Health & Science University has uncovered how small molecules within bacteria interact with proteins, revealing a network of molecular connections that could improve drug discovery and cancer research.
Combined strategy can prevent pancreatic cancer drug resistance
Understanding the mechanisms of resistance to cancer treatments is necessary to find effective therapies at different stages of the disease. Scientists at UT Southwestern Medical Center studied the most frequent mutation in pancreatic ductal adenocarcinoma (PDAC), identified an escape route to a therapy in clinical trials, blocked it with another experimental compound and reduced tumors in mice.
Researchers use “hallmarks of cancer” to understand tumour growth
A team led by the Cancer Immunogenomics group at the Josep Carreras Leukaemia Research Institute, the Computational Biology group at the Barcelona Supercomputing Center and the Germans Trias i Pujol Research Institute shows, for the first time, that within a tumour, the expression of the different hallmarks of cancer is not cell-specific, but rather position-specific.
FDA Approves Trastuzumab Deruxtecan for Pretreated HER2-Low and -Ultralow Metastatic Breast Cancer
The FDA approved T-DXd for unresectable/metastatic HR+, HER2-low/-ultralow breast cancer that progressed on endocrine therapy in the metastatic setting.
Cordance Medical and EXACT Therapeutics Announce Early Encouraging Data in Brain Cancer Mice Model
/PRNewswire/ — Cordance Medical, a pioneer in non-invasive medical technologies for brain disease treatment, and EXACT Therapeutics (Euronext Growth: EXTX), a…
A superfruit from Brazil may boost treatment for cancer, diabetes, obesity
A superfruit from Brazil may boost treatment for cancer, diabetes, obesity
Peptide-Coated Nanoparticles Enhance Drug Delivery for Cancer Treatment
A new study reveals that peptide-coated nanoparticles can improve the delivery and efficacy of cancer drugs, potentially reducing side effects.
Addition to T Cell Expansion Media Leads to Improved Antitumor Efficacy in Mice
Researchers identify glucose usage as one major divergence betweenT cells expanding in vitro versus those expanding in vivo.
From COVID-19 testing to a breakthrough in cancer treatment monitoring
Innovations originally developed for COVID-19 testing are now being applied to monitor cancer treatments more effectively.
Enhertu Approved for HR+, HER2-Low/Ultralow Metastatic Breast Cancer
Approval of the new indication was based on data from the phase 3 DESTINY-Breast06 trial.
